Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Seufferlein

Showing results (291-300 of 367) with videos related to

Pageof 37
Sort By:
Scientific Reports|April 16, 2026
A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinomaKanishka Tiwary, Anton Lahusen, Syeda Inaas, et al.
United European Gastroenterology Journal|January 19, 2026
Remote Pancreatic Response to Severe Polytrauma Correlates With Clinical OutcomeRebecca Halbgebauer, Lisa Wohlgemuth, Jonas Wrba, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 3, 2022
[Further Development and Interoperability in Oncological Care Structures, Quality Control and Research]Monika Klinkhammer-Schalke, Simone Wesselmann, Johannes Bruns, et al.
Journal of Medical Internet Research|June 21, 2021
Metadata Correction: Patient Empowerment During the COVID-19 Pandemic by Ensuring Safe and Fast Communication of Test Results: Implementation and Performance of a Tracking SystemGunnar Völkel, Axel Fürstberger, Julian D Schwab, et al.
Journal of Cancer Research and Clinical Oncology|January 17, 2025
Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome- paving the path towards precision medicine: a case reportCarolin Seeling, Sonja Dahlum, Ralf Marienfeld, et al.
Cancers|June 2, 2021
A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment ResponseAlica K Beutel, Lena Schütte, Jeanette Scheible, et al.
BMC Biology|March 21, 2023
TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regenerationMichael Karl Melzer, Silvia Schirge, Johann Gout, et al.
BMC Cancer|December 31, 2018
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer groupThomas J Ettrich, Andreas W Berger, Lukas Perkhofer, et al.
Journal of Medical Internet Research|May 17, 2021
Patient Empowerment During the COVID-19 Pandemic by Ensuring Safe and Fast Communication of Test Results: Implementation and Performance of a Tracking SystemGunnar Völkel, Axel Fürstberger, Julian D Schwab, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|April 16, 2021
[Heidelberg Milestones Communication (HeiMeKOM) - Experiences, Best Practice Examples and Recommendations from the Final Symposium on January 30 and 31 in 2020]Matthias Villalobos, Nicole Deis, Simone Wesselmann, et al.
Pageof 37

Showing results (291-300 of 367) with videos related to

Sort By:
Pageof 37
Scientific Reports|April 16, 2026
A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinomaKanishka Tiwary, Anton Lahusen, Syeda Inaas, et al.
United European Gastroenterology Journal|January 19, 2026
Remote Pancreatic Response to Severe Polytrauma Correlates With Clinical OutcomeRebecca Halbgebauer, Lisa Wohlgemuth, Jonas Wrba, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 3, 2022
[Further Development and Interoperability in Oncological Care Structures, Quality Control and Research]Monika Klinkhammer-Schalke, Simone Wesselmann, Johannes Bruns, et al.
Journal of Medical Internet Research|June 21, 2021
Metadata Correction: Patient Empowerment During the COVID-19 Pandemic by Ensuring Safe and Fast Communication of Test Results: Implementation and Performance of a Tracking SystemGunnar Völkel, Axel Fürstberger, Julian D Schwab, et al.
Journal of Cancer Research and Clinical Oncology|January 17, 2025
Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome- paving the path towards precision medicine: a case reportCarolin Seeling, Sonja Dahlum, Ralf Marienfeld, et al.
Cancers|June 2, 2021
A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment ResponseAlica K Beutel, Lena Schütte, Jeanette Scheible, et al.
BMC Biology|March 21, 2023
TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regenerationMichael Karl Melzer, Silvia Schirge, Johann Gout, et al.
BMC Cancer|December 31, 2018
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer groupThomas J Ettrich, Andreas W Berger, Lukas Perkhofer, et al.
Journal of Medical Internet Research|May 17, 2021
Patient Empowerment During the COVID-19 Pandemic by Ensuring Safe and Fast Communication of Test Results: Implementation and Performance of a Tracking SystemGunnar Völkel, Axel Fürstberger, Julian D Schwab, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|April 16, 2021
[Heidelberg Milestones Communication (HeiMeKOM) - Experiences, Best Practice Examples and Recommendations from the Final Symposium on January 30 and 31 in 2020]Matthias Villalobos, Nicole Deis, Simone Wesselmann, et al.
Pageof 37